"Drug Compounding" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814)
Descriptor ID |
D004339
|
MeSH Number(s) |
E05.916.270
|
Concept/Terms |
Drug Compounding- Drug Compounding
- Compounding, Drug
- Drug Preparation
- Drug Preparations
- Preparation, Drug
- Preparations, Drug
Drug Formulation- Drug Formulation
- Drug Formulations
- Formulation, Drug
- Formulations, Drug
- Pharmaceutical Formulation
- Formulation, Pharmaceutical
- Formulations, Pharmaceutical
- Pharmaceutical Formulations
|
Below are MeSH descriptors whose meaning is more general than "Drug Compounding".
Below are MeSH descriptors whose meaning is more specific than "Drug Compounding".
This graph shows the total number of publications written about "Drug Compounding" by people in this website by year, and whether "Drug Compounding" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 2 | 3 |
1998 | 0 | 1 | 1 |
1999 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2006 | 0 | 2 | 2 |
2007 | 0 | 2 | 2 |
2008 | 0 | 2 | 2 |
2009 | 2 | 1 | 3 |
2010 | 0 | 1 | 1 |
2011 | 0 | 3 | 3 |
2012 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2016 | 1 | 1 | 2 |
2017 | 0 | 2 | 2 |
2018 | 0 | 4 | 4 |
2019 | 3 | 5 | 8 |
2020 | 1 | 3 | 4 |
2021 | 0 | 3 | 3 |
2022 | 0 | 2 | 2 |
2023 | 0 | 2 | 2 |
2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Compounding" by people in Profiles.
-
Pramar YV. Microbiological Stability of Allopurinol, Clindamycin Hydrochloride, Naltrexone Hydrochloride, Spironolactone and Ursodiol Oral Liquids Compounded in PCCA Base, SuspendIt?. Int J Pharm Compd. 2024 Jul-Aug; 28(4):316-320.
-
Pramar YV, Davis C, Ip K, Banov D. Physicochemical and Microbiological Stability of Compounded Bethanechol Chloride Oral Suspensions in PCCA Base, SuspendIt?. Int J Pharm Compd. 2024 Jul-Aug; 28(4):321-328.
-
Pramar YV, Mandal TK, Bostanian LA, Johnson J, Graves RA. Physicochemical and Microbiological Stability of Compounded Clonidine Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt?. Int J Pharm Compd. 2024 Jul-Aug; 28(4):334-343.
-
Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2023 Jul-Aug; 27(4):330-339.
-
Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt. Int J Pharm Compd. 2023 Mar-Apr; 27(2):160-168.
-
Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt. Int J Pharm Compd. 2022 Jul-Aug; 26(4):342-351.
-
Dasari S, Njiki S, Mbemi A, Yedjou CG, Tchounwou PB. Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy. Int J Mol Sci. 2022 Jan 28; 23(3).
-
De la Rosa MVG, B?ez JPF, Roma?ach RJ, L?pez-Mej?as V, Stelzer T. Real-time concentration monitoring using a compact composite sensor array for in situ quality control of aqueous formulations. J Pharm Biomed Anal. 2021 Nov 30; 206:114386.
-
Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2021 Sep-Oct; 25(5):431-439.
-
Pramar YV, Mandal TK, Bostanian LA, Le G, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt. Int J Pharm Compd. 2021 Mar-Apr; 25(2):169-175.